“The company is still trading at an attractive discount to book value and we look forward to the company further ramping up its operations in 2021,” Moermann says. Sunningdale closed on $1.23, compared to its net asset value of $2 per share and its net tangible asset of $1.93 per share.
From a precision engineering company, Sunningdale has diversified into healthcare with the production of medical disposables such as bloodline, drug delivery, critical care, caps & closures), airway management devices and components, hearing aid components, orthopedic components, permanent implacnt medical devices and optometric devices.
